Abstract
Objectives: Presently, more than one third of women in the United State are obese (BMI ≥30). Obesity significantly increases the relative risk of the development of both endometrial hyperplasia and cancer. However, once diagnosed, quality of survivorship of obese women is worse than that for nonobese patients. Our objective was to assess the feasibility of technology-based weight loss interventions in this patient population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
